Delivery Order V797D5007E-VA24115J0474

The Defense Logistics Agency Troop Support Medical awarded a $3,311.50 firm fixed price delivery order to Amerisourcebergen Drug Corp for ESBRIET 267 MG CAPSULE 270S. As the parent company, Amerisourcebergen Corporation will provide the pharmaceutical products to fulfill the order. To be completed by November 1, 2023, the contract has no set-aside designation. Esbriet is a medication used to treat idiopathic pulmonary fibrosis, a chronic lung disease, and this order will support the DLA Troop...

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ESBRIET 267 MG CAPSULE 270S. The contract has a ceiling value of $3,311.50 and a completion date of May 28, 2024. It is a firm fixed price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Esbriet (pirfenidone) 267 mg tablets in a quantity of 270 units, valued at $3,610.42. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 18, 2025, and fulfillment will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Esbriet is a prescription medication used to treat idiopathic...

This federal contract award, with an ID of SPE2DB22D1017|SPE2DB25FE7QR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESBRIET 267 MG CAPSULE 270S, with a ceiling value of $3,311.50 and a period of performance ending on November 12, 2024. The contract is a Delivery Order under a Firm Fixed Price type, with no set-aside designation. Amerisourcebergen Drug...

This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. for the delivery of 90-count bottles of the prescription drug ESBRIET (pirfenidone) 801 mg tablets. The contract has a ceiling value of $3,311.50 and an ultimate completion date of September 19, 2024. It is a Firm Fixed Price Delivery Order, with no set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain to...

The Defense Logistics Agency awarded a $9,934.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561401031 ESBRIET 267 MG CAPSULE 270S. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and will be performed by Amerisourcebergen at its facility located in Conshohocken, Pennsylvania. The period of performance is July 3, 2023 through July 25, 2023. No subcontractors or set aside designations were identified....

This federal contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESBRIET 267 MG CAPSULE 270S, a medical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop...

This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on May 15, 2025. The $3,425.95 contract is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with a performance period ending on June 6, 2025. The contract is not set aside and was awarded under the DLA's $999,999,999.00 Indefinite Delivery Contract (IDC) designated as SPE2DX, which provides a comprehensive global...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ESBRIET 267 MG CAPSULE 270S. The contract has a potential value of $3,311.50 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is a prime contractor that has previously provided a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities. This delivery...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $3,311.50, is for the delivery of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with...